AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Zealand Pharma

Director's Dealing May 25, 2023

3391_rpt_2023-05-25_9b4674e7-244c-4236-8ae9-908a910f357b.pdf

Director's Dealing

Open in Viewer

Opens in native device viewer

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1. Details of the person discharging managerial responsibilities/person closely associated
a) Name Adam Steensberg
2. Reason for the notification
a) Position/status Chief Executive Officer
b) Initial notification/Amend
ment
Initial notification
3. tion monitor Details of the issuer, emission allowance market participant, auction platform, auctioneer or auc
a) Name Zealand Pharma A/S,
CVR-no. 20045078
b) LEI1 549300ITBB1ULBL4CZ12
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type
of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial
instrument, type of instru
ment
Performance Stock Units
Identification code DK0060257814
b) Nature of the transaction Vesting and allocation of Performance Stock Units
c) Price(s) and volume(s) Price(s) Volume(s)
DKK 264.4 71,120
d) Aggregated information
-
Aggregated volume
-
Price
71,120
18,804,128
DKK
e) Date of the transaction 25
May
2023
f) Place of the transaction Outside trading Venue

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1. Details of the person discharging managerial responsibilities/person closely associated
a) Name Adam Steensberg
2. Reason for the notification
a) Position/status Chief Executive Officer
b) Initial notification/Amend
ment
Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auc
tion monitor
a) Name Zealand Pharma A/S,
CVR-no. 20045078
b) LEI1 549300ITBB1ULBL4CZ12
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type
of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial
instrument, type of instru
ment
Shares
Identification code DK0060257814
b) Nature of the transaction Sale of Shares
To Cover Tax
c) Price(s) and volume(s) Price(s) Volume(s)
DKK 270.44 19,100
d) Aggregated information
-
Aggregated volume
-
Price
19,100
5,165,327.80 DKK
e) Date of the transaction 25
May
2023
f) Place of the transaction Nasdaq Copenhagen

Talk to a Data Expert

Have a question? We'll get back to you promptly.